Functional Vs Disease Medicine, Cartoons 12-29-2017

                    CATCH MY INTERVIEW WITH

                WORLD FAMOUS  CARDIOLOGIST            

ADAM SPLAVER                               


1 | P a g e
Curriculum Vitae
NanoHealth Assoc.
3700 Washington St. – Suite 400 330 West 41tst St. Suite 217
Hollywood, FL 33021 Miami Beach, FL 33140
Ph:954-980-0361 Ph:305-760-8756
Fax:754-200-0335 Fax:305-760-8759
7/2014 – Present NanoHealth Associates – Partner and Co-Founder
Clinical and Preventative Cardiology/Internal Medicine
3/2015 – Present Diagnostic Partners – Interpret Echocardiographic studies remotely
1994 – Present Consultant – MedMaster Inc. – Edit books for publication such as Cardiology Made Ridiculously
Simple, USMLE Step 1 Made Ridiculously Simple, Acids Bases and Electrolytes Made
Ridiculously Simple, Radiology Made Ridiculously Simple, Behavioral Science for USMLE Made
Ridiculously Simple.
1/11/11 – 1/31/16 Memorial Healthcare System – Medical Director of Echocardiography
5 Hospitals – Memorial Regional, Memorial South, Memorial Pembroke, Memorial West
and Memorial Miramar
Upgraded/migrated system from dictated to structured reporting
Obtained initial IAC certification for the Memorial Hospital System – one of the largest at
the time to receive certification.
Managed over 70 sonographers and over 50 Echo readers
Over 20,000 studies performed/year
7/2004 – 7/2014 Florida Institute for Cardiovascular Care, PA, dba Healthworx, Hollywood, FL
2011 – Present University of Miami, Leonard M. Miller School of Medicine, Miami, FL
Voluntary Assistant Professor of Medicine
2/2009 – 7/2014 South Florida Research Solutions, LLC
Miramar, FL
2/2008- Present Nova Southeastern University, Davie, FL
Clinical Assistant Professor, Dept. Internal Medicine, Div. of Cardiology
7/2001 -6/2004 Mount Sinai Medical Center, Miami Beach, FL
Fellowship – Cardiology
7/1999 – 6/2001 Mount Sinai Medical Center, Miami Beach, FL
Residency – Internal Medicine
7/1998 – 6/1999 Mount Sinai Medical Center, Miami Beach, FL
Internship – Internal Medicine
2 | P a g e
Medical School
9/1994 – 6/1998 Albert Einstein College of Medicine of Yeshiva University, Bronx, NY
9/1990 – 6/1994 Yeshiva College, New York, NY
B.A. Biology, Cum Laude
9/1989 – 6/1990 Yeshivat Ohr Yerushalayim, Beit Meir, Israel
2004-2024 Board Certified – ABIM – Cardiology
2004-2024 Board Certified NBE- Echocardiography
2003-2013 Diplomate – Certification Board of Nuclear Cardiology
2001-2021 Diplomate – American Board of Internal Medicine
2011 – Present ARDMS RPVI – Registered Physician in Vascular Interpretation
2011 The Cenegenics Education & Research Foundation – Age Management Medicine
2014 A4M – Certification in Anti-aging and Regenerative Medicine
2013 – Present Member of the TAVR team – Memorial Healthcare System
2014 – Present Member of the Advanced Heart Failure and Transplant Team – Memorial Healthcare
2013 – Present Member of the Cardiovascular Executive Committee – Memorial Healthcare System
2014 – Present Member of the Mitra-Clip Committee – Memorial Healthcare System
HOSPITAL Memorial Regional Hospital
Memorial South
PRIVILEGES Memorial Hospital West
Memorial Hospital Miramar
Memorial Hospital Pembroke
Aventura Hospital
LICENSURE Florida Medical License
New York Medical License
Wisconsin Medical License
Pennsylvania Medical License
New Jersey Medical License
1994 Professor Mayer Atlas Memorial Award for Excellence in Biology.
Yeshiva College, New York, NY
1989 –1994 Samuel Belkin Memorial Scholarship.
3 | P a g e
Yeshiva College, New York, NY
1989 –1994 Dean’s List. (all semesters) – Yeshiva College, New York, NY
LANGUAGES English, Hebrew, Spanish
2002 – Present President and Board Member – Young Israel of Hollywood/Ft. Lauderdale, FL,
2002 -2011 First Vice President and Board Member – Brauser Maimonides Academy, Ft. Lauderdale, FL
2002 – 2004 Board Member – Cardiovascular Committee – Mount Sinai Medical Center/Miami Heart Institute,
Miami Beach, FL
1994 – 1995 Associate Instructor of Biology – Yeshiva College, Cell Biology Laboratory
1993 – 1994 Teacher’s Assistant – Columbia University, Cell and Developmental Biology Laboratory
Summer 1994 Program Director – ACHY. Headed and developed a program to tutor English and Math to newly
arrived Ethiopian and Russian immigrants to Haifa, Israel.
1991-1994 Assistant Director – Y.U.S.S.R. – Organized over 10 summer camp programs scattered
throughout the former Soviet Union. Participated in running a summer camp program in Tallinn
1991- 1995 Lifeguard –Yeshiva College
A. Manheimer-Lory, R. Monhian, A. Splaver, B. Gaynor, and B. Diamond. “Analysis of the VkI family: Germline genes form
an SLE patient and expressed autoantibodies.” Autoimmunity, 1995, Vol 20, pp. 259-265.
A.Manheimer-Lory, M. Irigoyen, B. Gaynor, R. Monhian, A. Splaver, and B. Diamond. “Analysis of VkI and VlII light chain
genes in the expressed B-cell repertoire.” Annals of the New York Academy of Sciences, Sept 29,1995, Vol 764, pp. 301-
A. Splaver, S. Silos, B. Lowell, R. Valenzuela, and R. Kirsner,“Case Report: Pemphigus Vulgaris in a Patient Infected With
HIV” AIDS Patient Care & Standards, June 2000, Vol 14(6), pp. 295-296.
A. Splaver , G. Lamas, C. Hennekens,”Homocysteine and Cardiovascular Disease: Biological Mechanisms, Observational
Epidemiology and the Need for Randomized Trials: Homocysteine and Cardiovascular Disease” In press, AHJ for August
1993 – 1994 Research Assistant – Columbia University
Ofra Weinberger, PhD, Investigated the role of soluble, extracellular tat and rev particles an
HIV and JC expression.
1992 – 1992 Roth Institute Scholar – Albert Einstein College of Medicine
Betty Diamond, M.D., Analyzed the role of somatic mutation on the development of antids-DNA
antibodies in Lupus patients
2004 – 2011 EARLY ACS – EARLY Glycoprotein IIB/IIIa Inhibition in Non-ST-segemtn Elevation Acute
Coronary Syndrome: A Ranomized, Placebo-Controilled Trial Evaluating the Clinical Benefits of
Early Front-Loaded Eptifibatide in the Treatment of Patient with Non-ST-segment Elevation
Acute Coronary Syndrome.
Sponsor: Schering-Plough Role: Sub- Investigator
2005 – 2007 IMPROVE IT – A Multicenter, Double-Blind, Randomized Study to Establish the Clinical
Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs. Simvastatin
4 | P a g e
Monotherapy in High-Risk Subjects Presenting with Acute Coronary Syndrome
(IMProved Reduction of Outcomes: Vytorin Efficacy International Trial – IMPROVE IT
Sponsor: Merck Role: Sub Investigator
2005 – 2008 RE-LY STUDY Randomized Evaluation of Long term anticoagulant therapy (RE-LY) comparing
the efficacy and safety of two blinded doses of dabigatran etexilate with open label warfarin for
the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation:
prospective, multi-centre, parallel-group, non-inferiority trial (RE-LY STUDY)
Sponsor: Boehringer Ingelheim Role: Sub-Investigator
2007 – 2007 ASCEND-HF Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical
Effectiveness of Nesiritide in Subjects With Decompensated Heart Failure
Sponsor: Scios Role: Sub-Investigator
2007 – 2009 ROCKET AF STUDY A Prospective, Randomized, Double-Blind, Double-Dummy,
Parallel-Group, Multicenter, Event-Driven, Non-Inferiority Study Comparing the Efficacy
and Study Drug With Adjusted-Dose Oral Warfarin for the Prevention of Stroke and Non-
Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial
Sponsor: Johnson-Johnson Role: Sub-Investigator
2007 – 2011 ARISTOTLE STUDY Apixaban for Reduction In STroke and Other ThromboemboLic
Events in Atrial Fibrillation A Phase 3, active (Warfarin) controlled Randomized, Double-
Blind Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing
Stroke and Systemic Embolism in Subjects with Nonvalvular Atrial Fibrillation
Sponsor: Bristol Myers Squibb Role: Sub-Investigator
2010 – 2014 ORBIT-AF – A Phase IV Outcome Registry for Better Informed Treatment of Atrial Fibrillation
Sponsor: Duke Clinical Research Institute Role: Principal Investigator
2010 – 2011 ALECARDIO.- A Multicenter, randomized, double blind, placebo-controlled cardiovascular
outcomes study to evaluate the potential of aleglitazar to reduce cardiovascular risk in patients
with a recent acute coronary syndrome (ACS) event and type 2 diabetes mellitus (T2D).
Sponsor: ROCHE Role: Sub-Investigator
2010 – 2011 REVEAL IN-OFFICE.- Implant Study, a prospective, non-randomized, multi-center post-market
clinical Trial to gather evidence about the safety and feasibility of performing the implant
procedure for the Reveal Insertable Cardiac Monitor (ICM) in an office or clinic setting.
Sponsor: Medtronic Role: Principal Investigator
2011 – 2013 TERISA STUDY.- A Phase 4, Randomized, Double-Blind, Placebo-Controlled, Parallel
Study of Ranolazine in Subjects with Chronic Stable Angina and Coronary Artery
Disease with a History of Type 2 Diabetes Mellitus
Sponsor: Gilead Role: Principal Investigator
5 | P a g e
2011 – 2012 BREVIBLOC.- A Phase IV, Multicenter, Observational Study Evaluating Hemodynamic
Outcomes with Brevibloc Premixed Injection (Esmolol Hydrochloride) in Patients with
Supraventricular Tachycardia/Atrial Fibrillation in Medical and Neurological Intensive
Care Units in the United States
Sponsor: Baxter Inc. Role: Principal Investigator
2011 – 2014 LV-BTD- Retrospective Study of Outcomes in Heart Failure Patients treated with
LifeVest as Bridge to Decision
Sponsor: Zoll Role: Principal Investigator
2013 – 2014 GLORIA – AF: Global Registry on Long-Term Oral Anti-thrombotic TReatment In
Patients with Atrial Fibrillation (Phase II/III)
Sponsor: Boehringer Ingelheim Role: Principal Investigator
2013 – 2014 ORBIT-AF II – A Phase IV Outcomes Registry for Better Informed Treatment of Atrial
Sponsor: Duke Clinical Research Institute Role: Principal Investigator
2013 – 2014 X-Vert 15693 – A prospective, randomized, open-label, parallel-group,
active-controlled, multicenter study exploring the efficacy and safety of once-daily
oral rivaroxaban (BAY 59-7939) compared with that of dose-adjusted oral
vitamin K antagonists (VKA) for the prevention of cardiovascular events in subjects
with nonvalvular atrial fibrillation scheduled for cardioversion
Sponsor: Bayer Healthcare Role: Principal Investigator
2013 – 2014 EFFECT AF – Relative Effectiveness of Dronedarone vs. Other Treatments of Atrial
Sponsor: LaSer Research Role: Principal Investigator
2013 – 2014 AF Wave 1 – Real-world Study Evaluating Dronedarone Treatment Patterns and Outcomes in
Patients with Atrial Fibrillation: Wave 1
Sponsor: United Biosource Corporation Role: Principal Investigator

Catch Me On FaceBook Live

Every Weekday and Saturday

If You Enjoy These Send A Link To Your Friends

more non PC stuff,  pissing progressives off for a living

let me inform you , let me entertain you, let me piss you off


© 2016 2 Old Guys, LLC.  All rights reserved

Share this kick-ass content


Orest is a 65 year old blogger, internet marketer, standup comedian and health care professional that lives in Phoenix, Arizona with his wife and two kids. When you meet Orest you will be surprised (the cover does not match the man) to find him funny, edgy and very casual, most of the time his filter is often off. His wife and kids often have to tell him to “grow up”. If you piss him off you will find that he can turn into a DICK real fast. Orest REALLY enjoys spending time with his wife and kids!!!!! Drinkin fine liquor and smoking cigars while watching UFC, football and basketball are favorite pastimes. He falls asleep during baseball and soccer. Occasionally he will read a book if there are a lot of pictures in it. For keeping fit Orest likes to lift heavy weights and hike Squaw Peak. If forced too he will do Yoga, actually he got plantar fasciitis in Yoga. Orest is looking to live the next stages of his life full of kick ass shit. He wants to share those experiences with you and wants to hear about yours. Join Orest by signing up to get his 5 Rules Of Life and get regular notifications about Weekday Political Cartoons and other KOOL shit.

Leave a Reply

Share with your Friends or Those you want to Irritate!